Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.
about
Immunoinformatics comes of ageMUC4 gene polymorphisms associate with endometriosis development and endometriosis-related infertilityIdentification of protein p270/Tpr as a constitutive component of the nuclear pore complex-attached intranuclear filamentsNuclear and nucleolar targeting of human ribosomal protein S6Characterization of kinectin, a kinesin-binding protein: primary sequence and N-terminal topogenic signal analysisCloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2Anti-HSP90 autoantibodies in sera of infertile women identify a dominant, conserved epitope EP6 (380-389) of HSP90 beta proteinDNA-binding and -bending activities of SAP30L and SAP30 are mediated by a zinc-dependent module and monophosphoinositidesScansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifsTwo mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiencyCloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophilsComparisons of the M1 genome segments and encoded mu2 proteins of different reovirus isolatesVaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalkIdentification of four epitopes in hepatitis C virus core proteinIdentification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteinsHomology of the 74-kD cytoplasmic dynein subunit with a flagellar dynein polypeptide suggests an intracellular targeting functionAntibodies against specific extracellular epitopes of the glucagon receptor block glucagon bindingGenome variability and capsid structural constraints of hepatitis a virus.The major phase-variable outer membrane protein of Escherichia coli structurally resembles the immunoglobulin A1 protease class of exported protein and is regulated by a novel mechanism involving Dam and oxyRPet, an autotransporter enterotoxin from enteroaggregative Escherichia coli.Autodisplay: one-component system for efficient surface display and release of soluble recombinant proteins from Escherichia coli.Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.Anaplasma phagocytophilum surface protein AipA mediates invasion of mammalian host cells.Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus.The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine DesignImmunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.In silico-based vaccine design against Ebola virus glycoproteinComputational prediction of conformational B-cell epitopes from antigen primary structures by ensemble learning.Chimeric Dr fimbriae with a herpes simplex virus type 1 epitope as a model for a recombinant vaccine.What a polyclonal antibody sees in von Willebrand factor.Antibody-protein interactions: benchmark datasets and prediction tools evaluationDiversity of Ehrlichia ruminantium major antigenic protein 1-2 in field isolates and infected sheep.Evaluation of an in silico predicted specific and immunogenic antigen from the OmcB protein for the serodiagnosis of Chlamydia trachomatis infections.Prediction of antigenic epitopes on protein surfaces by consensus scoringCellular hyperimmunoreactivity to rubella virus synthetic peptides in chronic rubella associated arthritisEPSVR and EPMeta: prediction of antigenic epitopes using support vector regression and multiple server results.Evaluation of the Schistosoma mansoni Y-box-binding protein (SMYB1) potential as a vaccine candidate against schistosomiasis.In Silico Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein.
P2860
Q21145682-25DA46FA-C829-4030-A731-74454CACE110Q21245255-8984DC32-A5EF-4156-9F0D-B931E38672DCQ24318735-0CC7B404-8277-4B36-A8E9-12D5697928C5Q24321240-C924228A-F69E-4E45-9D8A-EF024264BFBEQ24322808-7BE3DDE4-ABF7-453B-ABB0-31628C110FE7Q24534167-584B3C1C-4122-4A24-B3B0-0D22EE27139AQ24621980-A83D68D3-B718-4DE5-B12F-73F458FEC525Q24655211-08E1D3AF-FB99-4B7E-8C82-78FD6A1F4D01Q24671990-A7653AAF-C4D1-4D65-8AC3-27339E0E39E6Q24672534-06D48458-8558-429E-8F59-F91E51AAAE0AQ24682594-AE55141C-3A5D-4A16-9B21-E158670D0EF6Q24804331-AAFB0E92-A8D5-4603-9DCF-C577DD97159DQ27486872-5B8C764C-C883-4DDD-B58C-75C8D0183E94Q27488214-7356F3CE-3619-4F6E-AB3F-B0B19712F25AQ27489953-549DAC56-2146-4161-BCD1-BC8C02EAA4EAQ28119724-1592DE49-62F3-4847-B475-E65E175AC096Q28573143-9E5A1641-C6E5-4883-9B05-21A7B9E28271Q28581696-9BBC5FB7-5718-4066-A4FD-DD6071B39C48Q30165022-740C3700-6915-4909-8528-7785FBF25522Q30175814-9325FE2E-2E37-4EEE-80A9-90FAD3FDF455Q30176142-76474A99-824A-41AE-B3E0-9793F0A3511FQ30176650-A10A75F5-C474-4615-825B-A3D6C16C8F7EQ30356755-587FDB58-7F4A-4360-985F-D57A17935B93Q30371557-4B89EFB8-BB79-4AA3-8E37-7269DCAD9DACQ30382230-9EBA42EF-9BEB-4880-BC2C-6215B611237EQ30393728-067B65C6-46F9-45AB-BCBD-979616114C05Q30400430-9DBAF98B-D1F9-48A8-89B4-FFF54218FE0FQ30423481-29F0FD8E-1645-453C-999D-21BF9F7410CDQ30843053-3A6DF0D3-0DB3-446B-83C7-4CF290B1D8AEQ31087675-05647D43-617E-42AB-9B8D-7BB66BE6B98EQ33193073-7AEF41DB-A2B4-4B05-B359-3DBB90226BE9Q33290062-B8C1B561-4D02-4BC9-B6A9-51FC393468B0Q33301223-E4BBBCE3-7D53-4138-9D11-B802E0BCC2FEQ33346926-34D22BA9-9CCD-491D-91B6-2418A906B2D0Q33392388-8601EDC8-2E67-44B3-84E7-D77F7B5D453DQ33505826-B3A82CD3-6F8C-44BD-B480-37D3DF7F377BQ33565698-886816B5-AA11-4511-9446-AFB9ED4B2DA6Q33634626-609D031B-6503-4331-8D54-AB92B1B262EDQ33738522-445DE783-AB2B-49BA-9F9D-6E9B8E163379Q33753964-2DDEEE70-FEE4-4DFE-9051-894C0E331C46
P2860
Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Induction of hepatitis A virus ...... us-specific synthetic peptide.
@en
type
label
Induction of hepatitis A virus ...... us-specific synthetic peptide.
@en
prefLabel
Induction of hepatitis A virus ...... us-specific synthetic peptide.
@en
P2093
P2860
P1433
P1476
Induction of hepatitis A virus ...... us-specific synthetic peptide.
@en
P2093
P2860
P304
P407
P577
1985-09-01T00:00:00Z